AUTOLOGOUS ANTI-GD2 CAR-T CELLS EFFICIENTLY TARGET PRIMARY HUMAN GLIOBLASTOMA

被引：0
|
作者：
Chiavelli, C. [1 ]
Rovesti, G. [1 ,2 ,3 ]
Prapa, M. [1 ,4 ]
Neri, G. [1 ,2 ]
Pugliese, G. [1 ,5 ]
Trudu, L. [1 ,2 ,3 ]
Silingardi, M. [1 ]
Dall'Ora, M. [6 ]
Golinelli, G. [1 ,7 ]
Grisendi, G. [1 ]
Bestagno, M. [8 ]
Spano, C. [6 ]
Papapietro, R. V. [3 ]
Depenni, R. [3 ]
Di Emidio, K. [3 ]
Pasetto, A. [9 ,10 ]
Silva, D. Nascimento [10 ]
Feletti, A. [11 ]
Berlucchi, S. [12 ]
Iaccarino, C. [12 ]
Pavesi, G. [12 ]
Dominici, M. [1 ,3 ,6 ]
机构：
[1] Dept Med & Surg Sci Children & Adults, Div Oncol, Lab Cellular Therapy, Modena, Italy
[2] Univ Modena & Reggio Emilia, Clin & Expt Med PhD Program, Modena, Italy
[3] Univ Hosp Modena & Reggio Emilia, Univ Hosp Modena, Dept Hematol & Oncol, Modena, Italy
[4] Univ Barleti, Dept Med Tech Sci, Tirana, Albania
[5] Guys Hosp, Leucid Bio Ltd, London, England
[6] Evotec Modena Srl, Evotec, Modena, Italy
[7] Perelman Sch Med, Ctr Cellular Immunotherapies, Philadelphia, PA USA
[8] Icgeb, Trieste, Italy
[9] Oslo Univ Hosp, Sect Cell Therapy, Radiumhosp, Oslo, Norway
[10] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[11] Univ Verona, Dept Neurosci Biomed & Movement Sci, Neurosurg Unit, Verona, Italy
[12] Univ Hosp Modena, Div Neurosurg, Dept Neurosci, Modena, Italy
来源：
HUMAN GENE THERAPY | 2023年 / 34卷 / 21-22期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P099
引用
收藏
页码：A42 / A43
页数：2
相关论文
共 50 条
  • [31] Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
    Mount, Christopher W.
    Majzner, Robbie G.
    Sundaresh, Shree
    Arnold, Evan P.
    Kadapakkam, Meena
    Haile, Samuel
    Labanieh, Louai
    Hulleman, Esther
    Woo, Pamelyn J.
    Rietberg, Skyler P.
    Vogel, Hannes
    Monje, Michelle
    Mackall, Crystal L.
    NATURE MEDICINE, 2018, 24 (05) : 572 - +
  • [32] Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
    Christopher W. Mount
    Robbie G. Majzner
    Shree Sundaresh
    Evan P. Arnold
    Meena Kadapakkam
    Samuel Haile
    Louai Labanieh
    Esther Hulleman
    Pamelyn J. Woo
    Skyler P. Rietberg
    Hannes Vogel
    Michelle Monje
    Crystal L. Mackall
    Nature Medicine, 2018, 24 : 572 - 579
  • [33] ENHANCING GLIOBLASTOMA TREATMENT: ALLOGENEIC CAR-T CELLS OVERCOMES FUNCTIONAL DEFICITS OF PATIENT-DERIVED AUTOLOGOUS PRODUCTS
    Shaikh, Muhammad Vaseem
    Salim, Sabra K.
    Maich, William T.
    Ananad, Alisha
    Wei, Jeffrey
    Subapanditha, Minomi K.
    Suk, Yujin
    Singh, Manoj
    Tabunshchyk, Zoya
    Chen, Katie
    Vora, Parvez
    Venugopal, Chitra
    Moffat, Jason
    Singh, Sheila K.
    NEURO-ONCOLOGY, 2024, 26
  • [34] Anti-GD2 CAR T cells could prove transformative for H3-K27M+ diffuse midline gliomas
    Furukawa, Koichi
    Ohmi, Yuhsuke
    Furukawa, Keiko
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S87 - S93
  • [35] Early Detection of Tonic Signaling in Primary Human CAR-T Cells by Flow Cytometry
    Nguyen, John
    MOLECULAR THERAPY, 2023, 31 (04) : 387 - 387
  • [36] GD2 CAR-T cells in combination with Nivolumab exhibit enhanced antitumor efficacy
    Zhang, Guangji
    Zhao, Yu
    Liu, Zhongfeng
    Liu, Weihua
    Wu, Huantong
    Wang, Xuan
    Chen, Zhiguo
    TRANSLATIONAL ONCOLOGY, 2023, 32
  • [37] B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
    Tang, Xin
    Zhao, Shasha
    Zhang, Yang
    Wang, Yuelong
    Zhang, Zongliang
    Yang, Meijia
    Zhu, Yanyu
    Zhang, Guanjie
    Guo, Gang
    Tong, Aiping
    Zhou, Liangxue
    MOLECULAR THERAPY-ONCOLYTICS, 2019, 14 : 279 - 287
  • [38] HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
    Ahmed, Nabil
    Salsman, Vita S.
    Kew, Yvonne
    Shaffer, Donald
    Powell, Suzanne
    Zhang, Yi J.
    Grossman, Robert G.
    Heslop, Helen E.
    Gottschalk, Stephen
    CLINICAL CANCER RESEARCH, 2010, 16 (02) : 474 - 485
  • [39] GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
    Gargett, Tessa
    Ebert, Lisa M.
    Truong, Nga T. H.
    Kollis, Paris M.
    Sedivakova, Kristyna
    Yu, Wenbo
    Yeo, Erica C. F.
    Wittwer, Nicole L.
    Gliddon, Briony L.
    Tea, Melinda N.
    Ormsby, Rebecca
    Poonnoose, Santosh
    Nowicki, Jake
    Vittorio, Orazio
    Ziegler, David S.
    Pitson, Stuart M.
    Brown, Michael P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [40] Immune determinants of CAR-T expansion in solid tumor patients receiving GD2 CAR-T cell therapy
    Murty, Tara
    Kaczanowska, Sabina
    Alimadadi, Ahmad
    Contreras, Cristina
    Duault, Caroline
    Balasubrahmanyan, Priyanka
    Reynolds, Warren
    Gutierrez, Norma
    Baskar, Reema
    Wu, Catherine
    Michor, Franziska
    Altreuter, Jennifer
    Liu, Yang
    Jhaveri, Aashna
    Duong, Vandon
    Anbunathan, Hima
    Moravec, Radim
    Hong, Joyce
    Biswas, Roshni
    Van Nostrand, Stephen
    Lindsay, James
    Pichavant, Mina
    Sotillo, Elena
    Sahaf, Bita
    Bendall, Sean
    Maecker, Holden
    Highfill, Steven
    Stroncek, David
    Merchant, Melinda
    Glod, John
    Hedrick, Catherine
    Mackall, Crystal
    Ramakrishna, Sneha
    Kaplan, Rosandra
    CANCER RESEARCH, 2023, 83 (07)
12345